ATH — Alterity Therapeutics Share News
0.000.00%
- AU$1.96m
- -AU$47.14m
- AU$0.45m
Australia Stock Exchange release from ALTERITY THERAPE : Alterity to Present at the 34th Annual Roth Conference
Australia Stock Exchange release from ALTERITY THERAPE : NASDAQ Non-Compliance Notice Received
On 23 February Received Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement - SEC Filing
Australia Stock Exchange release from ALTERITY THERAPE : Half Yearly Report and Accounts
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 14:34:22
Australia Stock Exchange release from ALTERITY THERAPE : New publication shows ATH434 rescues neurons in MSA model
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 13:58:39
Australia Stock Exchange release from ALTERITY THERAPE : Appendix 4C and Quarterly Cash Flow Report
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 14:58:47
Australia Stock Exchange release from ALTERITY THERAPE : Change in substantial holding
Australia Stock Exchange release from ALTERITY THERAPE : Response to ASX Query
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 08:43:21
Australia Stock Exchange release from ALTERITY THERAPE : Change in substantial holding
Alterity Therapeutics soars on patent win for neurodegenerative treatments
Australia Stock Exchange release from ALTERITY THERAPE : PRE_NR Ends: 10:26:36
Australia Stock Exchange release from ALTERITY THERAPE : New US Patent for Compounds to Treat Neurodegeneration
Australia Stock Exchange release from ALTERITY THERAPE : Alterity to present at H.C. Wainwright Conference
Australia Stock Exchange release from ALTERITY THERAPE : Final Director's Interest Notice x 2
Australia Stock Exchange release from ALTERITY THERAPE : Notification of cessation of securities - ATH